January 19, 2023
The Minnesota Department of Health (MDH) is considering modifications to the Communicable Disease Reporting Rules through the Minnesota rulemaking process. This process will update the rules to address new and emerging communicable diseases, remove unnecessary provisions, clarify reporting conditions, and address other technical changes.
MDH published the “Request for Comments” (RFC) on January 17 and will be accepting comments until March 20 at 4:30pm. MDH encourages physicians to review the RFC and submit comments. MDH will publish the specific modifications to the rules later this year.
For a copy of the RFC and the rulemaking process, visit the MDH’s website at Amendment to Rules Governing Communicable Disease Reporting.
For more information on the amendments and the rulemaking process, contact Patricia Segal Freeman, Minnesota Department of Health, PO Box 9441, St. Paul, MN 55164-0975, phone (651) 201-5414 or 1-877-676-5414; fax 1 (800) 233-1817; email: health.Commdisrule@state.mn.us.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.